ABS Blog

In the previous blog post, I introduced ABS’ Core Values. These values stem from our goal to be a company that performs to the highest standards for our clients over the long term. I also discussed Excellence: what it means in an operational sense, and what we do to sustain it. Excellence is not possible without Accountability, our next Core Value.

At ABS, we are going through an exercise to clarify and evaluate our Core Values from a performance perspective. This exercise is based upon a book by Natalie Dawson, TEAMWORK How to Build a High-Performance Team. The values that we selected are meant to be actionable and drive our decisions on hiring, rewarding high-performance, and firing. They are intended to guide our individual and company performance.

I am going a bit out on a limb here and tackle a somewhat different topic than usual because we should be prepared for what may come. Right now, our industry is doing very well. We are coming off successes with the COVID vaccines, and there are major new discoveries in many areas. Employment is at an all-time high. However, there are headwinds ahead. Inflation rates are high. This erodes buying power for individuals and corporations. Central banks are raising interest rates to control inflation. Historically, such increases have often led to recession. In addition, political pressures are pushing to lower drug costs. Whatever side of the debate you are on with respect to this issue, lower revenues could impact future R&D.

Most of us have had the experience of being inundated with phone calls and marketing materials, only to later to have difficulty receiving a price quote or follow up after you place an order. We understand how frustrating this is.

For the past three decades we have asked our clients to complain. While we strive to get everything done exactly right every time, we know that may not always happen. No organization can guarantee that. It is far better to hear bad news or learn of a shortcoming than not to hear of an issue. That way, problems are solved, and processes are improved.

As one might expect, selecting a provider for cell culture services has many things in common with selecting other types of services providers. There are also factors that are specific to cell culture. This post describes both general and specific criteria and how you can tell in advance that those criteria are likely to be met.

ABS grows very large numbers of cell lines for our clients. Projects range from Master and Working cell banks, hundreds of assay ready cell vials, to cell pellets from hundreds of billions of cells. Cells must pass QC for Mycoplasma and bacterial contamination, must be stored, and shipped on time to the proper locations throughout the world. In addition, various cell culture reports must be uploaded to the client portal, emailed to clients or in some cases entered directly into our clients’ electronic notebooks.

This post is not about how to write a scientific paper, which is a disciplined and rigorous process. It is about communicating science with one another and non-scientists. It is inspired by an interview with Alan Alda that I recently heard and by observing interactions between our clients and other scientists over several decades.

Flexibility is generally viewed as good. ABS is built upon flexibility. We provide custom biological products and services rather than one size fits all solutions to solve our clients’ problems. Flexibility is implicit in our business operations.

This week ABS is having a meeting of our Advisory Board. Our Advisory Board is composed of experts in a number of disciplines. This upcoming meeting was an inspiration for this topic. It occurred to me that we serve in a similar capacity with many of our clients because we do far more than provide highly customized products and services. We also act as trusted advisors in many areas.